The emerging role of autophagy and mitophagy in tauopathies: From pathogenesis to translational implications in Alzheimer’s disease DOI Creative Commons
Xiao‐Lan Liu, Meng Ye, Liang Ma

et al.

Frontiers in Aging Neuroscience, Journal Year: 2022, Volume and Issue: 14

Published: Oct. 17, 2022

Alzheimer’s disease (AD) is the most prevalent neurodegenerative disease, affecting more than 55 million individuals worldwide in 2021. In addition to “amyloid hypothesis,” an increasing number of studies have demonstrated that phosphorylated tau plays important role AD pathogenesis. Both soluble oligomers and insoluble aggregates brain can induce structural functional neuronal damage through multiple pathways, eventually leading memory deficits neurodegeneration. Autophagy cellular response various stress stimuli generally be categorized into non-selective selective autophagy. Recent indicated both types autophagy are involved pathology. Among several subtypes autophagy, mitophagy, which mediates removal mitochondria, has attracted attention because dysfunctional mitochondria been suggested contribute tauopathies. this review, we summarize latest findings on bidirectional association between abnormal proteins defective as well might constitute a vicious cycle induction Neuroinflammation, another feature pathogenesis progression AD, shown crosstalk with mitophagy. Additionally, comprehensively discuss relationship neuroinflammation, By elucidating underlying molecular mechanisms governing these pathologies, highlight novel therapeutic strategies targeting mitophagy such those using rapamycin, urolithin, spermidine, curcumin, nicotinamide, actinonin, for prevention treatment AD.

Language: Английский

Curcumin, a Natural Antimicrobial Agent with Strain-Specific Activity DOI Creative Commons
Artur Adamczak, Marcin Ożarowski, Tomasz M. Karpiński

et al.

Pharmaceuticals, Journal Year: 2020, Volume and Issue: 13(7), P. 153 - 153

Published: July 16, 2020

Curcumin, a principal bioactive substance of turmeric (Curcuma longa L.), is reported as strong antioxidant, anti-inflammatory, antibacterial, antifungal, and antiviral agent. However, its antimicrobial properties require further detailed investigations into clinical multidrug-resistant (MDR) isolates. In this work, we tested curcumin's efficacy against over 100 strains pathogens belonging to 19 species. This activity was determined by the broth microdilution method calculating minimum inhibitory concentration (MIC). Our findings confirmed much greater sensitivity Gram-positive than Gram-negative bacteria. study exhibited significantly larger variation in curcumin previous works suggested that numerous widespread have poor curcumin. Similarly, MICs MDR types Staphylococcus aureus, S. haemolyticus, Escherichia coli, Proteus mirabilis were high (≥2000 µg/mL). effective some species strains: Streptococcus pyogenes (median MIC = 31.25 µg/mL), methicillin-sensitive aureus (250 Acinetobacter lwoffii individual Enterococcus faecalis Pseudomonas aeruginosa (62.5 The not associated with affiliation genus, it could differ lot (e.g., pyogenes, agalactiae A. lwoffii, baumannii). Hence, can be considered promising antibacterial agent, but very selective activity.

Language: Английский

Citations

270

Therapeutic Approach to Alzheimer’s Disease: Current Treatments and New Perspectives DOI Creative Commons
Teresa Pardo-Moreno, Anabel González‐Acedo, Antonio Rivas-Domínguez

et al.

Pharmaceutics, Journal Year: 2022, Volume and Issue: 14(6), P. 1117 - 1117

Published: May 24, 2022

Alzheimer’s disease (AD) is the most common cause of dementia. The pathophysiology this characterized by accumulation amyloid-β, leading to formation senile plaques, and intracellular presence neurofibrillary tangles based on hyperphosphorylated tau protein. In therapeutic approach AD, we can identify three important fronts: approved drugs currently available for treatment disease, which include aducanumab, donepezil, galantamine, rivastigmine, memantine, a combination memantine donepezil; therapies under investigation that work mainly Aβ pathology pathology, γ-secretase inhibitors, β-secretase α-secretase modulators, aggregation metal interfering drugs, enhance clearance, inhibitors protein hyperphosphorylation, promote clearance tau, finally, other alternative designed improve lifestyle, thus contributing prevention disease. Therefore, aim review was analyze describe current treatments possible future alternatives in AD.

Language: Английский

Citations

130

The Multifaceted Role of Curcumin in Advanced Nanocurcumin Form in the Treatment and Management of Chronic Disorders DOI Creative Commons
Priti Tagde,

Pooja Tagde,

Fahadul Islam

et al.

Molecules, Journal Year: 2021, Volume and Issue: 26(23), P. 7109 - 7109

Published: Nov. 24, 2021

Curcumin is the primary polyphenol in turmeric's curcuminoid class. It has a wide range of therapeutic applications, such as anti-inflammatory, antioxidant, antidiabetic, hepatoprotective, antibacterial, and anticancer effects against various cancers, but poor solubility low bioavailability. Objective: To improve curcumin's bioavailability, plasma concentration, cellular permeability processes. The nanocurcumin approach over curcumin been proven appropriate for encapsulating or loading (nanocurcumin) to increase its potential. Conclusion: Though incorporating into form may be viable method overcoming intrinsic limitations, there are reasonable concerns regarding toxicological safety once it enters biological pathways. This review article mainly highlights benefits curcumin.

Language: Английский

Citations

124

Role of natural products for the treatment of Alzheimer's disease DOI

Tayebeh Noori,

Ahmad Reza Dehpour, Antoni Sureda

et al.

European Journal of Pharmacology, Journal Year: 2021, Volume and Issue: 898, P. 173974 - 173974

Published: Feb. 27, 2021

Language: Английский

Citations

120

The gut-brain vascular axis in neuroinflammation DOI Creative Commons
Sara Carloni, María Rescigno

Seminars in Immunology, Journal Year: 2023, Volume and Issue: 69, P. 101802 - 101802

Published: July 7, 2023

The multifaceted microbiota characterizing our gut plays a crucial role in maintaining immune, metabolic and tissue homeostasis of the intestine as well distal organs, including central nervous system. Microbial dysbiosis is reported several inflammatory intestinal diseases characterized by impairment epithelial vascular barriers, defined leaky gut, it potential danger condition associated with development metabolic, neurodegenerative diseases. Recently, we pointed out strict connection between brain via novel axis. Here want to deepen knowledge on gut-brain axis, particular emphasis microbial dysbiosis, cerebral firm association axis will be summarized context protection, amelioration or boosting Alzheimer, Parkinson, Major depressive Anxiety disorders. Understanding relationship disease pathophysiology, mucosal barrier function host-microbe interaction foster use microbiome biomarker for health target therapeutic nutritional advances.

Language: Английский

Citations

59

Neuroprotective and anti‐inflammatory effects of curcumin in Alzheimer's disease: Targeting neuroinflammation strategies DOI
Elena Azzini, Sheila I. Peña‐Corona,

Héctor Hernández‐Parra

et al.

Phytotherapy Research, Journal Year: 2024, Volume and Issue: 38(6), P. 3169 - 3189

Published: April 14, 2024

Abstract Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by the accumulation of amyloid‐beta plaques and neurofibrillary tangles, leading to neuronal loss. Curcumin, polyphenolic compound derived from Curcuma longa , has shown potential neuroprotective effects due its anti‐inflammatory antioxidant properties. This review aims synthesize current preclinical data on anti‐neuroinflammatory mechanisms curcumin in context AD, addressing pharmacokinetics, bioavailability, as therapeutic adjunct. An exhaustive literature search was conducted, focusing recent studies within last 10 years related curcumin's impact neuroinflammation role AD. The methodology included sourcing articles specialized databases using specific medical subject headings terms ensure precision relevance. Curcumin demonstrates significant properties modulating neuroinflammatory pathways, scavenging reactive oxygen species, inhibiting production pro‐inflammatory cytokines. Despite potential, challenges remain regarding limited bioavailability scarcity comprehensive human clinical trials. emerges promising adjunct AD multimodal benefits. However, further research required overcome establish effective dosing regimens subjects. Developing novel delivery systems formulations may enhance treatment.

Language: Английский

Citations

30

Curcumin and Its Derivatives as Theranostic Agents in Alzheimer’s Disease: The Implication of Nanotechnology DOI Open Access
Umair Shabbir,

Momna Rubab,

Akanksha Tyagi

et al.

International Journal of Molecular Sciences, Journal Year: 2020, Volume and Issue: 22(1), P. 196 - 196

Published: Dec. 27, 2020

Curcumin is a polyphenolic natural compound with diverse and attractive biological properties, which may prevent or ameliorate pathological processes underlying age-related cognitive decline, Alzheimer’s disease (AD), dementia, mode disorders. AD chronic neurodegenerative disorder that known as one of the rapidly growing diseases, especially in elderly population. Moreover, being eminent cause posing problems for families, societies well severe burden on economy. There are no effective drugs to cure AD. Although curcumin its derivatives have shown properties can be considered useful inhibiting hallmarks AD, however, they low bioavailability. Furthermore, combat diagnostic therapeutic limitations, various nanoformulations also been recognized theranostic agents enhance pharmacokinetic other bioactive compounds. Nanocarriers beneficial deliver nutritional compounds against blood-brain barrier efficiently distribute them brain. This review spotlights role effectiveness Besides, gut metabolism effects nanoparticles their possible activity discussed.

Language: Английский

Citations

87

A review on ferulic acid and analogs based scaffolds for the management of Alzheimer’s disease DOI
Yash Pal Singh, Himanshu Rai, Gourav Singh

et al.

European Journal of Medicinal Chemistry, Journal Year: 2021, Volume and Issue: 215, P. 113278 - 113278

Published: Feb. 16, 2021

Language: Английский

Citations

78

Curcumin can improve Parkinson's disease via activating BDNF/PI3k/Akt signaling pathways DOI

Tian Jin,

Yong Zhang, Benson O. A. Botchway

et al.

Food and Chemical Toxicology, Journal Year: 2022, Volume and Issue: 164, P. 113091 - 113091

Published: May 6, 2022

Language: Английский

Citations

65

Role of curcumin in the treatment of acute kidney injury: research challenges and opportunities DOI
Yi Cai, Chaoming Huang, Mengyu Zhou

et al.

Phytomedicine, Journal Year: 2022, Volume and Issue: 104, P. 154306 - 154306

Published: July 4, 2022

Language: Английский

Citations

50